IMC 2.04% 9.6¢ immuron limited

$1.7 billion overnight, page-5

  1. 393 Posts.
    lightbulb Created with Sketch. 11
    Completely agree tarecq. Our NASH pipeline will be worth more than Tobira, never mind Cdiff, which itself should be over $1billion market cap. Add to this existing products that a Bigpharama can quickly increase revenues & along with opportunities in Diabetes. I think a Buyout price of $4 billion to $5billion seems reasonable for Immuron in late 2017, early 2018.
    Last edited by whittpa: 26/09/16
 
watchlist Created with Sketch. Add IMC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.